Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
OCUL
OCUL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OCUL News
Ocular Therapeutix Files NDA for Axpaxli, Plans Streamlined Trials
3d ago
stocktwits
Ocular Plans to Submit AXPAXLI NDA Application
3d ago
Newsfilter
Ocular Therapeutix Reaches NDA Agreement with FDA for Axpaxli Submission
3d ago
seekingalpha
Investment Comparison: Ocular Therapeutix vs. Prime Medicine
5d ago
Fool
Investment Choices: Ocular Therapeutix vs. Prime Medicine
5d ago
NASDAQ.COM
Ocular Therapeutix to Participate in Clinical Trials at Summit 2026
Jun 04 2026
Newsfilter
Acuta Capital Reduces Stake in Ocular Therapeutix Significantly
May 26 2026
Fool
Acuta Capital Partners Reduces Ocular Therapeutix Holdings
May 26 2026
NASDAQ.COM
Saturn V Capital Management Fully Exits Ocular Therapeutix
May 19 2026
Fool
Saturn V Fully Exits Ocular Therapeutix Stake
May 19 2026
NASDAQ.COM
Ocular Therapeutix Q1 2026 Earnings Call Insights
May 05 2026
seekingalpha
Ocular Therapeutix to Announce Q1 Earnings on May 5th
May 04 2026
seekingalpha
Ocular Therapeutix to Participate in Multiple Conferences
Apr 27 2026
Newsfilter
AXPAXLI Demonstrates Unmatched Durability in Wet AMD Treatment
Apr 13 2026
Newsfilter
Ocular Therapeutix Shares Surge 10.45% Ahead of Key Conferences
Apr 10 2026
Yahoo Finance
Ocular Therapeutix to Participate in Multiple Scientific Conferences
Apr 01 2026
Newsfilter
Show More News
